open access

Vol 30, No 3 (2023)
Original Article
Submitted: 2021-05-04
Accepted: 2021-08-27
Published online: 2021-09-23
Get Citation

Distinctive characteristics of His bundle potentials in patients with atrioventricular nodal reentrant tachycardia

Fu Guan12, Ardan M. Saguner1, Daniel Hofer1, Thomas Wolber1, Alexander Breitenstein1, Nazmi Krasniqi13, Urs Eriksson13, Jan Steffel1, Corinna Brunckhorst1, Firat Duru14
·
Pubmed: 34581428
·
Cardiol J 2023;30(3):431-439.
Affiliations
  1. Arrhythmia and Electrophysiology Division, Department of Cardiology, University Heart Center, Zurich, Switzerland
  2. Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
  3. Department of Cardiology, GZO Regional Health Center Wetzikon, Switzerland
  4. Center for Integrative Human Physiology, University of Zurich, Switzerland

open access

Vol 30, No 3 (2023)
Original articles — Clinical cardiology
Submitted: 2021-05-04
Accepted: 2021-08-27
Published online: 2021-09-23

Abstract

Background: His bundle (HB) potentials vary in amplitude and duration in patients with and without
slow pathways. The aim of this study was to determine the characteristics of HB potentials and to
elucidate whether they can provide clues for identification of slow pathway (SP).
Methods: The present research prospectively studied the electrophysiological findings of 162 patients
with symptomatic atrioventricular nodal reentrant tachycardia (AVNRT) due to slow-fast or fast-slow
type and atrioventricular reentrant tachycardia (AVRT). Maximal HB potential (HBmax, HB with the
highest amplitude) among HB cloud was recorded in both groups. For AVNRT patients, the following
were measured: (1) AH interval at the “jump” during programmed atrial stimulation (A2H2, taken
as a reflection of SP conduction time); (2) Distance from HBmax to the successful SP ablation site
(HBmax-ABL) and from HBmax to the ostium of coronary sinus (HBmax-CSO).
Results: HBmax was 0.29 ± 0.10 mV in AVNRT patients, whereas it was 0.17 ± 0.05 mV in AVRT
group (p < 0.0001). Likewise, the HBmax duration was 22 ± 5 ms in AVNRT group and 16 ± 3 ms
in AVRT group (p < 0.0001). The area under the receiver operating characteristic curve of HBmax
amplitude in AVNRT patients was 0.86 and the optimal HBmax cut-off to predict AVNRT was
≥ 0.22 mV with a sensitivity of 0.78 and specificity of 0.84. HBmax-CSO was positively correlated with
HBmax-ABL, and HBmax-ABL was positively correlated with A2H2.
Conclusions: HBmax amplitudes were higher and durations longer in patients with AVNRT, as
compared to those with AVRT. Moreover, the distance between HBmax and successful ablation site
was positively correlated with the SP conduction time and with the distance from HBmax to the CSO.

Abstract

Background: His bundle (HB) potentials vary in amplitude and duration in patients with and without
slow pathways. The aim of this study was to determine the characteristics of HB potentials and to
elucidate whether they can provide clues for identification of slow pathway (SP).
Methods: The present research prospectively studied the electrophysiological findings of 162 patients
with symptomatic atrioventricular nodal reentrant tachycardia (AVNRT) due to slow-fast or fast-slow
type and atrioventricular reentrant tachycardia (AVRT). Maximal HB potential (HBmax, HB with the
highest amplitude) among HB cloud was recorded in both groups. For AVNRT patients, the following
were measured: (1) AH interval at the “jump” during programmed atrial stimulation (A2H2, taken
as a reflection of SP conduction time); (2) Distance from HBmax to the successful SP ablation site
(HBmax-ABL) and from HBmax to the ostium of coronary sinus (HBmax-CSO).
Results: HBmax was 0.29 ± 0.10 mV in AVNRT patients, whereas it was 0.17 ± 0.05 mV in AVRT
group (p < 0.0001). Likewise, the HBmax duration was 22 ± 5 ms in AVNRT group and 16 ± 3 ms
in AVRT group (p < 0.0001). The area under the receiver operating characteristic curve of HBmax
amplitude in AVNRT patients was 0.86 and the optimal HBmax cut-off to predict AVNRT was
≥ 0.22 mV with a sensitivity of 0.78 and specificity of 0.84. HBmax-CSO was positively correlated with
HBmax-ABL, and HBmax-ABL was positively correlated with A2H2.
Conclusions: HBmax amplitudes were higher and durations longer in patients with AVNRT, as
compared to those with AVRT. Moreover, the distance between HBmax and successful ablation site
was positively correlated with the SP conduction time and with the distance from HBmax to the CSO.

Get Citation

Keywords

tachycardia, atrioventricular nodal reentry, slow pathway, His bundle, catheter ablation

About this article
Title

Distinctive characteristics of His bundle potentials in patients with atrioventricular nodal reentrant tachycardia

Journal

Cardiology Journal

Issue

Vol 30, No 3 (2023)

Article type

Original Article

Pages

431-439

Published online

2021-09-23

Page views

2362

Article views/downloads

524

DOI

10.5603/CJ.a2021.0107

Pubmed

34581428

Bibliographic record

Cardiol J 2023;30(3):431-439.

Keywords

tachycardia
atrioventricular nodal reentry
slow pathway
His bundle
catheter ablation

Authors

Fu Guan
Ardan M. Saguner
Daniel Hofer
Thomas Wolber
Alexander Breitenstein
Nazmi Krasniqi
Urs Eriksson
Jan Steffel
Corinna Brunckhorst
Firat Duru

References (20)
  1. Jackman WM, Beckman KJ, McClelland JH, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. 1992; 327(5): 313–318.
  2. Del Carpio Munoz F, Buescher TL, Asirvatham SJ. Three-dimensional mapping of cardiac arrhythmias: what do the colors really mean? Circ Arrhythm Electrophysiol. 2010; 3(6): e6–11.
  3. Haissaguerre M, Gaita F, Fischer B, et al. Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy. Circulation. 1992; 85(6): 2162–2175.
  4. Chua K, Upadhyay GA, Lee E, et al. High-resolution mapping of the triangle of Koch: Spatial heterogeneity of fast pathway atrionodal connections. Heart Rhythm. 2018; 15(3): 421–429.
  5. Damato AN, Lau SH, Berkowitz WD, et al. Recording of specialized conducting fibers (A-V nodal, His bundle, and right bundle branch) in man using an electrode catheter technic. Circulation. 1969; 39(4): 435–447.
  6. Kay GN, Epstein AE, Dailey SM, et al. Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia. Evidence for involvement of perinodal myocardium within the reentrant circuit. Circulation. 1992; 85(5): 1675–1688.
  7. Jazayeri MR, Hempe SL, Sra JS, et al. Selective transcatheter ablation of the fast and slow pathways using radiofrequency energy in patients with atrioventricular nodal reentrant tachycardia. Circulation. 1992; 85(4): 1318–1328.
  8. Wu D, Yeh SJ, Wang CC, et al. A simple technique for selective radiofrequency ablation of the slow pathway in atrioventricular node reentrant tachycardia. J Am Coll Cardiol. 1993; 21(7): 1612–1621.
  9. Geller JC, Biblo LA, Carlson MD. Relation between the AH interval and the ablation site in patients with atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol. 2004; 27(10): 1347–1354.
  10. Hirao K, Otomo K, Wang X, et al. Para-Hisian pacing. A new method for differentiating retrograde conduction over an accessory AV pathway from conduction over the AV node. Circulation. 1996; 94(5): 1027–1035.
  11. Obeyesekere M, Gula LJ, Modi S, et al. Tachycardia induction with ventricular extrastimuli differentiates atypical atrioventricular nodal reentrant tachycardia from orthodromic reciprocating tachycardia. Heart Rhythm. 2012; 9(3): 335–341.
  12. Patterson E, Scherlag BJ. Longitudinal dissociation within the posterior AV nodal input of the rabbit: a substrate for AV nodal reentry. Circulation. 1999; 99(1): 143–155.
  13. Zhang Y, Bharati S, Mowrey KA, et al. His electrogram alternans reveal dual-wavefront inputs into and longitudinal dissociation within the bundle of His. Circulation. 2001; 104(7): 832–838.
  14. Özkartal T, Stehli J, Duru F. Intermittent PQ prolongation between two premature ventricular complexes: what is the mechanism? Eur Heart J. 2016; 37(32): 2560.
  15. Natale A, Greenfield RA, Geiger MJ, et al. Safety of slow pathway ablation in patients with long PR interval: further evidence of fast and slow pathway interaction. Pacing Clin Electrophysiol. 1997; 20(6): 1698–1703.
  16. Lee SH, Chen SA, Tai CT, et al. Atrioventricular node reentrant tachycardia in patients with a prolonged AH interval during sinus rhythm: clinical features, electrophysiologic characteristics and results of radiofrequency ablation. J Interv Card Electrophysiol. 1997; 1(4): 305–310.
  17. Hucker WJ, McCain ML, Laughner JI, et al. Connexin 43 expression delineates two discrete pathways in the human atrioventricular junction. Anat Rec (Hoboken). 2008; 291(2): 204–215.
  18. Dagres N, Manolis AS, Maounis T, et al. Site of successful slow pathway ablation relates to clinical tachycardia rate in patients with atrioventricular nodal re-entrant tachycardia. Heart. 2006; 92(1): 115–116.
  19. Wu D, Denes P, Amat-y-Leon F, et al. Clinical, electrocardiographic and electrophysiologic observations in patients with paroxysmal supraventricular tachycardia. Am J Cardiol. 1978; 41(6): 1045–1051.
  20. Mills MF, Motonaga KS, Trela A, et al. Is there a difference in tachycardia cycle length during SVT in children with AVRT and AVNRT? Pacing Clin Electrophysiol. 2016; 39(11): 1206–1212.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl